Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25109102 |
US |
4 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 302 | 25109103 |
US |
81 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 303 | 25109124 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 304 | 25102614 |
US |
2 | |
Haemorrhage, |
||||
EVOLOCUMAB, |
||||
| 305 | 25102800 |
US |
62 | 1 |
Dizziness, Haemorrhage, Pain, Colitis ulcerative, Therapeutic product effect decreased, |
||||
UPADACITINIB, |
||||
| 306 | 25102818 |
US |
72 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 307 | 25102821 |
US |
17 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 308 | 25102822 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 309 | 25103065 |
US |
80 | 2 |
Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 310 | 25103080 |
US |
68 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 311 | 25103267 |
US |
10 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 312 | 25103386 |
US |
76 | 2 |
Skin reaction, Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 313 | 25103398 |
US |
64 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 314 | 25103456 |
US |
19 | 1 |
Haemorrhage, Skin reaction, |
||||
INSULIN LISPRO, |
||||
| 315 | 25103462 |
US |
77 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 316 | 25103537 |
US |
8 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 317 | 25103694 |
US |
28 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN GLARGINE, |
||||
| 318 | 25103696 |
US |
66 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 319 | 25103697 |
US |
78 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, |
||||
| 320 | 25103841 |
IN |
||
Haemorrhage, Pneumonia, Dyspnoea, |
||||
DURVALUMAB, |
||||
| 321 | 25103948 |
CN |
2 | |
Platelet count decreased, Gingival bleeding, Haemorrhage, Hypokalaemia, Bacterial infection, White blood cell count increased, C-reactive protein increased, Posterior capsule opacification, |
||||
NIFEDIPINE, BROMFENAC SODIUM, BROMFENAC SODIUM, ESOMEPRAZOLE SODIUM, |
||||
| 322 | 25103984 |
US |
42 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
| 323 | 25104278 |
US |
53 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 324 | 25104286 |
US |
||
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 325 | 25104393 |
US |
13 | 1 |
Haemorrhage, Arthralgia, |
||||
| 326 | 25104582 |
US |
32 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
| 327 | 25104658 |
ES |
||
Atrial fibrillation, Erythema nodosum, Neutropenia, Diarrhoea, Aphthous ulcer, Arthralgia, Hypertension, Haemorrhage, Anaemia, |
||||
VENETOCLAX, IBRUTINIB, |
||||
| 328 | 25104792 |
CN |
22 | 1 |
Disseminated varicella zoster virus infection, Multiple organ dysfunction syndrome, Cardiac arrest, Bacterial infection, Coagulopathy, Hyponatraemia, Hyperlactacidaemia, Haematological infection, Septic shock, Anuria, Myelosuppression, Respiratory failure, Haemorrhage, Arrhythmia, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 329 | 25107386 |
US |
89 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO, |
||||
| 330 | 25107387 |
US |
83 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 331 | 25107390 |
US |
65 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 332 | 25107403 |
US |
62 | 1 |
Autoimmune arthritis, Osteoporosis, Pituitary-dependent Cushing^s syndrome, Hypopituitarism, Adrenal insufficiency, Hypersensitivity, Kyphosis, Diastasis recti abdominis, Upper respiratory tract infection, Upper respiratory tract infection, Bronchitis, Anaphylactic reaction, Vaccination site pain, Vaccination site erythema, Vaccination site swelling, Chills, Pyrexia, Herpes zoster, Testicular disorder, Umbilical hernia, Quadriparesis, Pneumonia parainfluenzae viral, Rib fracture, Lymphadenopathy, COVID-19, Intestinal obstruction, Sepsis, Ecchymosis, Haemorrhage, Vitiligo, Heat stroke, COVID-19 pneumonia, Respiratory distress, Keratoacanthoma, Tooth fracture, Benign prostatic hyperplasia, Drug hypersensitivity, Fatigue, Arthralgia, Myalgia, Autonomic neuropathy, Wisdom teeth removal, Hydronephrosis, Gait disturbance, Apnoea, Arthralgia, Folate deficiency, Impaired gastric emptying, Neurogenic bowel, Drug ineffective, Gastrointestinal microorganism overgrowth, |
||||
PEMBROLIZUMAB, ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, GOLIMUMAB, PREDNISONE, INFLIXIMAB, ALENDRONATE SODIUM, |
||||
| 333 | 25097448 |
US |
68 | 2 |
Fall, Swelling, Haemorrhage, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 334 | 25097986 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 335 | 25097987 |
US |
67 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 336 | 25098081 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 337 | 25098086 |
US |
7 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 338 | 25098145 |
US |
79 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 339 | 25098154 |
US |
68 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, DULAGLUTIDE, |
||||
| 340 | 25098158 |
US |
3 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 341 | 25098224 |
US |
44 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 342 | 25098242 |
US |
1 | |
Haemorrhage, Pain, |
||||
| 343 | 25098296 |
US |
64 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 344 | 25098473 |
US |
12 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 345 | 25098476 |
US |
9 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 346 | 25098478 |
US |
79 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 347 | 25098700 |
US |
57 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 348 | 25098706 |
US |
69 | 1 |
Haemorrhage, Contusion, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 349 | 25098832 |
GR |
||
Hypothyroidism, Hypertension, Haemorrhage, Proteinuria, Acute kidney injury, Gastrointestinal haemorrhage, Diarrhoea, Hepatic failure, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 350 | 25098858 |
US |
78 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 351 | 25098861 |
US |
58 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, SEMAGLUTIDE, |
||||
| 352 | 25099002 |
US |
||
Haemorrhage, |
||||
RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE, |
||||
| 353 | 25099076 |
US |
60 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 354 | 25099077 |
US |
68 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 355 | 25099079 |
US |
63 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 356 | 25099201 |
US |
19 | 1 |
Influenza, Gastrointestinal disorder, Surgery, Haemorrhage, |
||||
DUPILUMAB, EMICIZUMAB, TADALAFIL, |
||||
| 357 | 25099206 |
US |
84 | 2 |
Haemorrhage, Contusion, Pruritus, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 358 | 25099208 |
US |
69 | 2 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, |
||||
| 359 | 25099215 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 360 | 25099216 |
US |
53 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 361 | 25099355 |
US |
5 | 1 |
Haemorrhage, Limb injury, Product dose omission issue, |
||||
| 362 | 25099569 |
US |
83 | 1 |
Blood urine present, Haemorrhage, Constipation, Gastrointestinal disorder, |
||||
APIXABAN, |
||||
| 363 | 25099633 |
US |
63 | 2 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 364 | 25099741 |
US |
29 | 2 |
Haemorrhage, Maternal exposure during pregnancy, Stillbirth, |
||||
WARFARIN, MISOPROSTOL, SPIRONOLACTONE, MIFEPRISTONE, FENTANYL, DOPAMINE HYDROCHLORIDE, DOPAMINE, |
||||
| 365 | 25099778 |
US |
63 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 366 | 25099906 |
US |
2 | |
Haemorrhage, Injury associated with device, Accidental exposure to product, |
||||
AFLIBERCEPT, |
||||
| 367 | 25099907 |
US |
2 | |
Haemorrhage, Injury associated with device, Accidental exposure to product, |
||||
AFLIBERCEPT, |
||||
| 368 | 25099913 |
US |
59 | 2 |
Haemorrhage, Contusion, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 369 | 25100306 |
US |
26 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 370 | 25100307 |
US |
54 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 371 | 25100721 |
US |
77 | 2 |
Haemorrhage, |
||||
AMBRISENTAN, TREPROSTINIL, TADALAFIL, SOTATERCEPT-CSRK, |
||||
| 372 | 25100761 |
US |
69 | 1 |
Erythema, Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 373 | 25100763 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 374 | 25100779 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 375 | 25100816 |
US |
41 | 1 |
Haemorrhage, Fall, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 376 | 25100817 |
US |
18 | 1 |
Haemorrhage, Off label use, |
||||
EMICIZUMAB, |
||||
| 377 | 25100869 |
US |
40 | 2 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 378 | 25100870 |
US |
43 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 379 | 25100981 |
US |
80 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 380 | 25101085 |
US |
86 | 1 |
Prostatic disorder, Haemorrhage, |
||||
APIXABAN, |
||||
| 381 | 25101090 |
US |
71 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 382 | 25101148 |
TW |
83 | 1 |
Cardiac amyloidosis, Pneumonia, Haemorrhage, Acute respiratory failure, Heart failure with preserved ejection fraction, Restrictive cardiomyopathy, Acquired ATTR amyloidosis, Dementia, Pleural effusion, Adrenal insufficiency, Cystitis, Acinetobacter infection, Escherichia infection, Skin infection, Eosinophilia, Drug eruption, Soft tissue infection, Urinary tract infection, Hypothyroidism, Aortic valve incompetence, Tricuspid valve incompetence, Aortic stenosis, Pulmonary hypertension, Ascites, Hyperbilirubinaemia, Hypertension, Off label use, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 383 | 25101319 |
GB |
1 | |
Haemorrhage, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, INFLIXIMAB, |
||||
| 384 | 25101360 |
US |
||
Death, Thrombocytopenia, Neutropenia, Leukopenia, Anaemia, Lymphopenia, Hyperglycaemia, Fatigue, Back pain, Hypocalcaemia, Infusion related reaction, Hypoalbuminaemia, Hyponatraemia, Aspartate aminotransferase increased, Dyspnoea, Headache, Hypophosphataemia, Pyrexia, Pneumonia, Pruritus, Hypertension, Plasma cell myeloma, Encephalopathy, Infection, Sinusitis, Hyperuricaemia, Therapy partial responder, Epistaxis, Chills, Therapy non-responder, Haemorrhage, Diarrhoea, Tachycardia, Nausea, Cough, Wheezing, |
||||
CARFILZOMIB, FILGRASTIM, DARATUMUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, |
||||
| 385 | 25101527 |
US |
28 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 386 | 25101528 |
US |
37 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 387 | 25101529 |
US |
61 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 388 | 25101652 |
US |
||
Device breakage, Haemorrhage, |
||||
TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, |
||||
| 389 | 25102052 |
US |
27 | 1 |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 390 | 25102116 |
US |
83 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 391 | 25105235 |
78 | 1 | |
Multiple injuries, Haemorrhage, Haematoma, Road traffic accident, |
||||
RIVAROXABAN, |
||||
| 392 | 25106354 |
61 | 1 | |
Haemorrhage, Melaena, Subdural haematoma, Acute myeloid leukaemia, |
||||
APIXABAN, |
||||
| 393 | 25106412 |
73 | 1 | |
Haemorrhage, Haematochezia, Abdominal hernia, Gastrointestinal haemorrhage, Deep vein thrombosis, |
||||
RIVAROXABAN, |
||||
| 394 | 25092101 |
CA |
89 | 1 |
Haematuria, Haemorrhage, |
||||
TAFAMIDIS MEGLUMINE, EDOXABAN TOSYLATE, ROSUVASTATIN, |
||||
| 395 | 25092416 |
US |
73 | 2 |
Blood glucose increased, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN ASPART, |
||||
| 396 | 25092422 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, INSULIN GLARGINE, |
||||
| 397 | 25092432 |
RO |
4 | 2 |
Hydrocephalus, Leukocytosis, Haemorrhage, |
||||
PHENOBARBITAL, |
||||
| 398 | 25092445 |
RO |
2 | 1 |
Foetal exposure during pregnancy, Premature baby, Hypercoagulation, Gene mutation, Myoclonic epilepsy, Haemorrhage, Generalised tonic-clonic seizure, Basal ganglia haemorrhage, |
||||
ENOXAPARIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 399 | 25092623 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO-AABC, |
||||
| 400 | 25092626 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28